Amount$165M
SeriesSeries B
AnnouncedFeb 24, 2020
SectorLife Sciences, Biotech, Genomics, Blood
Sub-sectorMachine Learning
Strong
A strong, well-structured round.
Round size vs peers
Far above the typical Series B round (5.9× the median) — an outlier.
Syndicate size
Healthy syndicate of 5 investors.
Insider conviction
5 existing investors re-upped — insiders doubling down.
Investor track record
Backed by established, high-track-record investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series B rounds (996)
Round size distribution96th pct
smaller Series B roundslarger
